Apnimed, Inc.
NASDAQ:APMDBiotechnology
+$0.71 today
- Market cap
- $726.46M
- Beta
- 0.00
Volume 0.30M
Average 1.15M
APMD EBITDA
Earnings before interest, taxes, depreciation, and amortization; a proxy for operating profit before non-cash and financing charges.
EBITDA history
Currency unavailable · from the income statement
No EBITDA data reported for this period type.
EBITDA vs competitors
How APMD compares with its peers on the latest reported figures
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Jun 2026 | $83.09M USD | -4.7% | — | 9.2% | |
| LTM Mar 2026 | -€77.16M EUR | -21.4% | — | 472.8% | |
APMDApnimed, Inc. | — | — | — | — | — |
| Peer median (excluding APMD) | — | -13.1% | — | 241.0% | |
Competitors are the stored peer set for APMD. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Apnimed, Inc.
NASDAQ:APMD
Intrinsic Alpha fair value
Locked
Current Price
$17.45
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.